Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study

MINI ABSTRACT: Real-world evidence on the comparative effectiveness and safety of abaloparatide versus teriparatide in women with osteoporosis may help inform treatment decisions. Following 18 months of treatment, abaloparatide was comparable to teriparatide for prevention of nonvertebral fractures,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosman, F., Cooper, C., Wang, Y., Mitlak, B., Varughese, S., Williams, S. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499892/
https://www.ncbi.nlm.nih.gov/pubmed/35524068
http://dx.doi.org/10.1007/s00198-022-06413-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499892/
https://www.ncbi.nlm.nih.gov/pubmed/35524068
http://dx.doi.org/10.1007/s00198-022-06413-y

Ejemplares similares